CVSA EBITDA Growth
7.90%TTM
Period ending:
CVSA TTM EBITDA YoY %%
82.34%-49.39%
2016-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
CVSA ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 39 observations from Dec 31, 2016 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 7.9022% | |
| 3.8592% | |
| 9.568% | |
| 15.978% | |
| 15.2993% | |
| 16.3888% | |
| 17.4091% | |
| 7.6378% | |
| 7.3399% | |
| 9.2703% | |
| 7.6927% | |
| 19.1632% | |
| 42.3936% | |
| 56.7842% | |
| 69.0007% | |
| 69.5902% | |
| 8.2303% | |
| -13.9851% | |
| -27.0529% | |
| -36.6445% | |
| -13.5755% | |
| -0.482% | |
| 14.9444% | |
| 23.2119% | |
| 18.632% | |
| 8.6926% | |
| -3.4211% | |
| -12.1666% | |
| -14.9536% | |
| -9.6811% | |
| -4.9019% | |
| 5.855% | |
| 1.8846% | |
| -1.3769% | |
| -9.0087% | |
| -16.0285% | |
| -10.3944% | |
| -7.431% | |
| -0.5431% |
Compare ebitda growth
All CVSA financial metrics · CVSA stock overview · How to interpret financial metrics
